ABOS CIK: 1576885

Acumen Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−18.0
FY22:
−35.2
FY23:
−43.1
FY24:
−86.2
FY25:
−116
Change from FY21 to FY25
millions USD
FY21:
−104
FY22:
39.2
FY23:
−172
FY24:
48.0
FY25:
134
Change from FY21 to FY25
millions USD
FY21:
200
FY22:
3.91
FY23:
152
FY24:
6.93
FY25:
−0.03
(positive)
Change from FY21 to FY25
millions USD
FY21:
−18.0
FY22:
−35.3
FY23:
−43.1
FY24:
−86.2
FY25:
−116

All amounts in millions USD Data source:SEC EDGAR